Login / Signup

Chronic phase subcutaneous implantable cardioverter defibrillator lead dislodgement in a patient with arrhythmogenic right ventricular cardiomyopathy.

Ryuki ChataniHiroshi TasakaAtsushi SakataMitsuru YoshinoKazushige Kadota
Published in: Pacing and clinical electrophysiology : PACE (2024)
The subcutaneous implantable cardioverter defibrillator (S-ICD) is often used in young patients such as arrhythmogenic right ventricular cardiomyopathy (ARVC) and Brugada syndrome due to long-term lead durability issues. Although S-ICD lead dislodgement is rare, we encountered such an incident in a young ARVC patient during the chronic phase following the two-incision technique. Remote monitoring system is useful for early diagnosis of electrode movement (Graphical abstract image). When S-ICD lead dislodgement occurs in active young patients, lead revision using the three-incision technique may be an option.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • heart failure
  • case report
  • prognostic factors
  • cardiovascular disease
  • middle aged
  • machine learning
  • atrial fibrillation